Cure SMA Awards $150,000 Grant to Alberto Kornblihtt, PhD, Universidad de Buenos Aires

Leave a Comment / Front Page News, Research /

Each year, Cure SMA invites scientists from around the world to submit funding proposals for basic research projects that address specific unanswered questions in SMA biology. Our Scientific Advisory Board ranks the submitted proposals on both their scientific merit and relevance to the Cure SMA research priorities. This year, Cure SMA’s top basic research priorities […]

Cure SMA Awards $150,000 Grant to Alberto Kornblihtt, PhD, Universidad de Buenos Aires Read More »

Cure SMA Unveils Advocacy 101 Video Series in Conjunction with 118th Congress

Leave a Comment / Advocacy, Front Page News /

Individuals with SMA and their families can learn how to advocate with their Members of Congress more effectively on issues important to them and the SMA community in a new advocacy 101 video series. In conjunction with the new 118th Congress, Cure SMA released a series of short, online videos that provide background on Congress

Cure SMA Unveils Advocacy 101 Video Series in Conjunction with 118th Congress Read More »

Share Your Air Travel Concerns & Experiences for Cure SMA Report to Congress

Leave a Comment / Advocacy, Front Page News /

The law that governs air travel in the United States is about to expire. Next year, Congress must consider air travel changes through a new Federal Aviation Administration (FAA) reauthorization bill. The last time the law was updated (2018), Congress included several provisions aimed at making air travel more accessible for people with disabilities. (For

Share Your Air Travel Concerns & Experiences for Cure SMA Report to Congress Read More »

SMA Community Progress & Advocacy Featured at Cure SMA Hope on the Hill Event

Leave a Comment / Advocacy, Front Page News /

Congressional leaders and key partners, supporters, and members of the spinal muscular atrophy (SMA) community celebrated SMA achievements and advocacy at Cure SMA’s 11th Annual Hope on the Hill Congressional Event. Hope on the Hill is an annual event to increase awareness about SMA and recognize policymakers and other key partners for helping to advance

SMA Community Progress & Advocacy Featured at Cure SMA Hope on the Hill Event Read More »

Cure SMA to Host 11th Annual Hope on the Hill Event in Washington, D.C.

Leave a Comment / Events & Fundraising, Front Page News, Our Impact /

On December 6th, Cure SMA will highlight the progress made in spinal muscular atrophy (SMA) and recognize the advocacy that helped lead to this success in a special event in our nation’s capital. Cure SMA has hosted an annual Hope on the Hill congressional dinner and reception in Washington, D.C. since 2010 to increase awareness

Cure SMA to Host 11th Annual Hope on the Hill Event in Washington, D.C. Read More »

Community Spotlight: Michelle Tynski and Family

Leave a Comment / Community Spotlight /

Play is important for kids. It allows children to develop cognitive, social, emotional, and physical skills while engaging creatively. But it’s not just how kids play that’s important, what they play with also matters. Which is why Michelle Tynski, mom to nine-year-old Trace, Benjamin who passed away in 2016, and 3-year-old Zach, who has Type

Community Spotlight: Michelle Tynski and Family Read More »

Positive New Data for Genentech’s Evrysdi in Largest Trial Ever Undertaken in Patients With Previously-Treated Spinal Muscular Atrophy (SMA)

Leave a Comment / Front Page News, Industry Updates /

Genentech, announced earlier this month new two-year data from the JEWELFISH study evaluating Evrysdi® (risdiplam) in people with Type 1, 2 or 3 SMA aged 6 months to 60 years at time of enrollment. Patients had been previously treated with other approved or investigational SMA-targeting therapies, including Spinraza® or Zolgensma®. Data showed Evrysdi improved or maintained motor function

Positive New Data for Genentech’s Evrysdi in Largest Trial Ever Undertaken in Patients With Previously-Treated Spinal Muscular Atrophy (SMA) Read More »

Scroll to Top